Ellevest, Inc. Seagen Inc. Transaction History

Ellevest, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$191.51 - $216.16 $66,262 - $74,791	346 Added 25.42%	1,707 $362,000
Q2 2023 Aug 09, 2023	BUY	$187.64 - $206.25 $20,640 - $22,687	110 Added 8.79%	1,361 $261,000
Q1 2023 May 04, 2023	BUY	$127.59 - $203.08 $45,294 - $72,093	355 Added 39.62%	1,251 $253,000
Q4 2022 Feb 03, 2023	SELL	$117.37 - $139.17 $81,806 - $97,001	-697 Reduced 43.75%	896 $115,000
Q3 2022 Nov 02, 2022	BUY	$135.27 - $180.11 $24,754 - $32,960	183 Added 12.98%	1,593 $218,000

Q2 2022 Jul 18, 2022	SELL	$108.81 - $179.33 $24,264 - $39,990	-223 Reduced 13.66%	1,410 $249,000
Q1 2022 Apr 19, 2022	BUY	$119.61 - $157.85 $56,934 - $75,136	476 Added 41.14%	1,633 $235,000
Q4 2021 Jan 24, 2022	SELL	$142.57 - $190.86 $8,981 - $12,024	-63 Reduced 5.16%	1,157 $179,000
Q3 2021 Oct 19, 2021	BUY	$142.45 - $169.82 $13,532 - $16,132	95 Added 8.44%	1,220 $207,000
Q2 2021 Jul 13, 2021	BUY	$135.08 - $161.1 $11,481 - $13,693	85 Added 8.17%	1,125 $178,000
Q1 2021 May 03, 2021	BUY	$137.51 - $190.8 $54,591 - $75,747	397 Added 61.74%	1,040 $144,000
Q4 2020 Feb 04, 2021	BUY	$164.63 - $211.93 $53,669 - $69,089	326 Added 102.84%	643 $113,000
Q3 2020 Oct 26, 2020	BUY	$145.95 - $195.69 $46,266 - $62,033	317 New	317 $62,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.